Myelodysplastic syndrome physical examination: Difference between revisions
Jump to navigation
Jump to search
Nawal Muazam (talk | contribs) No edit summary |
Nawal Muazam (talk | contribs) No edit summary |
||
Line 6: | Line 6: | ||
==Physical Examination== | ==Physical Examination== | ||
Common physical examination findings of myelodysplastic syndrome include:<ref name=cancergov4>Clinical features of myelodysplastic syndromes. National Cancer Institute (2015). http://www.cancer.gov/types/myeloproliferative/patient/myelodysplastic-treatment-pdq. Accessed on December 13, 2015</ref> | Common physical examination findings of myelodysplastic syndrome include:<ref name=cancergov4>Clinical features of myelodysplastic syndromes. National Cancer Institute (2015). http://www.cancer.gov/types/myeloproliferative/patient/myelodysplastic-treatment-pdq. Accessed on December 13, 2015</ref> | ||
*Weight loss | *Weight loss | ||
* | *Pallor | ||
*Hepatomegaly | |||
*Splenomegaly | |||
*Lymphadenopathy | *Lymphadenopathy | ||
*Diffuse erythematous rash | *Diffuse erythematous rash |
Revision as of 01:15, 14 December 2015
Myelodysplastic syndrome Microchapters |
Differentiating Myelodysplastic syndrome from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Myelodysplastic syndrome physical examination On the Web |
American Roentgen Ray Society Images of Myelodysplastic syndrome physical examination |
Risk calculators and risk factors for Myelodysplastic syndrome physical examination |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]
Overview
Common physical examination findings of myelodysplastic syndrome include fatigue, hepatomegaly, splenomegaly, and lymphadenopathy.[1]
Physical Examination
Common physical examination findings of myelodysplastic syndrome include:[1]
- Weight loss
- Pallor
- Hepatomegaly
- Splenomegaly
- Lymphadenopathy
- Diffuse erythematous rash
References
- ↑ 1.0 1.1 Clinical features of myelodysplastic syndromes. National Cancer Institute (2015). http://www.cancer.gov/types/myeloproliferative/patient/myelodysplastic-treatment-pdq. Accessed on December 13, 2015